Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is involved in the control of mood, emotion, and in various psychiatric diseases. Notably depression and generalized anxiety are causally linked, at least in part, to a dysfunction of the serotonergic system (Stahl et al., 2013) . To date, the most widely used antidepressants are selective inhibitors of serotonin reuptake (SSRI) leading to the idea that their therapeutic efficacy is mediated by an increase in extracellular 5-HT and the stimulation of serotonergic receptors. Among the numerous 5-HT receptors, the 5-HT 1A type (5-HT 1A R) has been proposed to play a key role in the mechanisms of antidepressant/anxiolytic actions of SSRI (Lanfumey and Hamon, 2000; Blier and Ward, 2003; Hensler, 2003) . 5-HT 1A R is confined to the somatodendritic compartment of both serotonergic neurons and target neurons of serotonergic projections where it acts as autoreceptor and heretoreceptor, respectively. The long-term tonic stimulation of 5-HT 1A R by 5-HT that occurs during chronic SSRI treatment has been shown to affect differentially 5-HT 1A autoreceptors in the dorsal raphe nucleus (DRN) and 5-HT 1A heteroreceptors in the hippocampus. Both in vivo and in vitro electrophysiological studies showed that a 2-3 week treatment with SSRI results in a functional desensitization of 5-HT 1A autoreceptors, without affecting postsynaptic 5-HT 1A R in hippocampus. Accordingly, after chronic SSRI treatment, the potency of direct 5-HT 1A R agonists to hyperpolarize the plasma membrane is markedly reduced in DRN serotonergic neurons, but is unaffected in hippocampal CA1 neurons (Lanfumey and Hamon, 2000) . Although numerous in vivo studies have been performed to elucidate what the cellular processes that underlie such brain region specificity of 5-HT 1A R desensitization are, the question is still largely unsolved. SSRI-induced desensitization of 5-HT 1A autoreceptors has been proposed to involve changes at the transcription level; however, these changes could not be correlated to modifications at the protein level (Le Poul et al., 2000) .
Studies from Riad et al. (2001 using immunocytochemical labeling coupled to electron microscopy, provided evidence that SSRI treatment induced 5-HT 1A R internalization in neurons in the raphe but not in the hippocampus. However, only acute treatment but not chronic treatment with SSRIs apparently produced a decreased expression of 5-HT 1A R at the somatodendritic plasma membrane of DRN neurons (Riad et al., 2008) , in sharp contradiction with the idea that receptor internalization could mediate, at least in part, chronic SSRI-induced functional desensitization demonstrated by electrophysiological recordings.
Because in vivo approaches have obvious limitations to investigate agonist-regulated receptor traffic in specific neuronal phenotypes, we addressed the question of 5-HT 1A R internalization and its control using the LLC-PK1 cell line and primary cultures of serotonergic raphe versus hippocampal neurons. Immunostaining strategies and live imaging allowed thorough studies of the traffic of 5-HT 1A R between plasma membrane and intracellular compartments under basal conditions and after acute or sustained exposure to 5-HT 1A R ligands. Striking differences between DRN serotonergic neurons and other cell types clearly showed that 5-HT 1A R agonist-induced internalization depends on agonist efficacy and cell phenotype.
Materials and Methods
Experiments were performed in strict agreement with the institutional guidelines for use of animals and their care, in compliance with national and international laws and policies 24 (Council directives no. 87-848, October 19, 1987 , Ministère de l'Agriculture et de la Forêt, Service Vétérinaire de la Santé et de la Protection Animale, permission no. 75-805 to J.M.).
Gestating female Sprague Dawley rats (Charles River Breeding Center) were maintained under controlled environmental conditions (21 Ϯ 1°C, 60% relative humidity, 12 h light/dark cycle), with food and water available ad libitum until killed for embryo removal.
Antibodies and markers. The following primary antibodies were used: anti-Flag M2 monoclonal antibody (1:2000; Sigma), rabbit anti-5-HT polyclonal antibody (1:100,000; Calbiochem). The secondary antibodies used were anti-mouse and anti-rabbit IgG Alexa Fluor 488-and 594-conjugated antibodies (1:500; Invitrogen), anti-mouse chicken IgG Alexa Fluor 594-conjugated antibody (1:800; Invitrogen), and anti-chicken goat IgG Alexa Fluor 488-conjugated antibodies (1:500; Invitrogen). LysoTracker Red DND-99 (100 nM), Transferrin-Alexa Fluor 546 conjugate (1: 1000 or 5 g/ml), ␣-bungarotoxin-Alexa Fluor 488 and 555 (BTX-AF488 and BTX-AF555, 1:1000) were purchased from Invitrogen. Plasmids. The rat 5-HT 1A R encoding sequence (Albert et al., 1990 ) was first inserted between the HindIII and EcoRI sites of the pCB6 vector, then a double-strand oligonucleotide coding sequence (5ЈAGCTATGT CAGGGCTCCAGGGAGCTCTCGTAGTATCTCCACAT-3Ј) for the minimum site of recognition for ␣-bungarotoxin (BTX), BTX binding site (BBS) (Sekine-Aizawa and Huganir, 2004) was inserted in the HindIII sites to generate the BBS-5-HT 1A construct. Plasmids encoding the rab4-GFP and rab5-GFP were as described previously (Sönnichsen et al., 2000) .
Cell cultures and transfection. LLC-PK1 cells were grown in DMEM (Invitrogen) supplemented with 4.5 g/L glucose, GlutaMAX I (Invitrogen), 10% fetal bovine serum, 10 U/ml penicillin G, and 10 mg/ml streptomycin. For stable transfection, the cDNA encoding BBS-5-HT 1A was transfected in LLC-PK1 cells by electroporation using the Gene Pulser Xcell electroporation system (Bio-Rad; 135 V, 1800 F in 200 l of DMEM containing 5-10 ϫ 10 6 cells and 5-10 g plasmid DNA; relaxation time: ϳ40 ms). Clones expressing the neomycin resistance marker were selected in G418 (1.25 mg/ml)-containing medium (Langlois et al., 1996) . After two passages, G418-resistant colonies were screened by observation of BTX fluorescence, and stably transfected clones were maintained in 0.4 mg/ml G418. For transient transfection, the cDNAs encoding rab4-GFP or rab5-GFP were transfected in BBS-5-HT 1A stably transfected LLC-PK1 cells with Lipofectamine 2000 (Invitrogen). Cells were used 24 h after transfection.
[ Preparation of membranes. Wild-type or transfected LLC-PK1 cells were washed with Dulbecco's phosphate buffer saline (DPBS; Invitrogen), scraped into Tris buffer (50 mM Tris-HCl, pH 7.4), and homogenized with a Polytron. After each of four successive washings in Tris buffer, the membranes were collected by centrifugation at 31,000 ϫ g for 20 min at 4°C. An incubation for 10 min at 37°C was performed after the first washing to eliminate 5-HT (from the serum in the culture medium), and the final pellet was suspended in the same Tris buffer to be stored at Ϫ80°C until use. Protein concentration was measured using BCA protein assay kit (Pierce).
Radioligand binding assays. Binding assays were performed using 1.6 nM [
3 H]LSD and 4 -20 g of membrane proteins in 500 l of 50 mM Tris-HCl, pH 7.4, supplemented with or without "cold" ligands at various concentrations. Samples were incubated for 90 min at 25°C, until rapid filtration through Whatman GF/B filters that had been precoated with polyethylenimine (0.5% v/v). Subsequent filter washing, counting of entrapped radioactivity, and calculations of relevant binding parameters were as described previously (Carrel et al., 2006 Carrel et al. (2006) . Briefly, membranes (ϳ50 g protein) were incubated for 30 min at 37°C in a final volume of 800 l assay buffer (50 mM Tris-HCl, pH 7.4, 4 mM MgCl 2 , 160 mM NaCl, 0.25 mM EGTA) containing 0.1 nM [
35 S]GTP␥S, 300 M GDP with or without 5-HT 1A R ligands (1 M), or BTX (100 M). The reaction was terminated by addition of 3 ml ice-cold 50 mM Tris-HCl buffer and rapid vacuum filtration through Whatman GF/B filters. Each filter was then placed into 4.5 ml scintillation fluid and its entrapped radioactivity measured using a Beckman counter. Basal [ 35 S]GTP␥S binding was determined from samples without 5-HT 1A R ligands or BTX. Triplicate determinations were made for each assay conditions. Lentiviral vector construction and production. BBS sequence was inserted upstream of the Flag-5-HT 1A R sequence (Carrel et al., 2006) in the expression plasmid pTrip-PGK-⌬U3 (SmaI/XhoI). Stocks of viral particles were produced as described previously (Zennou et al., 2000; Poulain et al., 2008) . HEK293T cells were transiently cotransfected with the pTrip-BBS-Flag-5-HT 1A R plasmid vector, the p8.9 encapsidation plasmid, and the pHCMV-G (vesicular stomatitis virus pseudotype) envelope plasmid by calcium phosphate precipitation. Briefly, the supernatants were collected 48 h after transfection, treated with DNase I (Roche Diagnostics) before ultracentrifugation, and then resuspended in PBS, aliquoted, and finally stored at Ϫ80°C until use. p24 capsid protein was quantified with an HIV-1 p24 ELISA antigen assay (Beckman Coulter). Lentiviral stocks averaged 50 ng/l p24 antigen.
Neuronal cell culture and lentiviral-mediated transduction. Neuronal cultures from hippocampi were made as described previously (Carrel et al., 2006 ) with slight modifications. Briefly, hippocampi were dissected from rat embryos at E18, incubated with trypsin, and tissue dissociation was achieved with a Pasteur pipette. Cells were counted and plated on poly-D-lysine-coated 14 mm diameter coverslips in a 10 cm dish, at a density of 1000,000 -1200,000 cells per dish (128 -154 cells/mm 2 ), in complete Neurobasal medium supplemented with B27 (Invitrogen), GlutaMAX I 100ϫ, 10 U/ml penicillin G, and 10 mg/ml streptomycin. For raphe neuron cultures, the brainstem area with B4 -B9 raphe nuclei was dissected from rat embryos at E14, and tissue dissociation and plating were done as for hippocampal neurons except that raphe neurons were plated at a density of 2200,000 -2500,000 cells per dish (280 -320 cells/mm 2 ). Two hours after plating, the culture medium was replaced by conditioned medium obtained by incubating glial cell cultures (70 -80% confluency) for 24 h in the complete medium described above. Conditioned medium was used as such or supplemented with the recombinant lentiviral vector suspension encoding BBS-Flag-5-HT 1A R. Neurons were kept with the same medium up to 12-14 days in vitro (DIV) for allowing receptor expression high enough for subsequent assays.
Immunofluorescence. Cells on coverslips were washed with DPBSϩ (DPBS containing 0.1 mM CaCl 2 and 0.1 mM MgCl 2 ) at 37°C, then fixed with 3% paraformaldehyde containing 4% sucrose (PFA/sucrose) at 37°C in DPBSϩ and permeabilized with 0.1% Triton X-100 in DPBS (without CaCl 2 , MgCl 2 ). After two washes (10 min) in DPBS, cells were incubated for 30 min in antibody buffer (3% bovine serum albumin, 2% normal goat serum, 2% normal donkey serum in DPBS). Incubation with primary antibodies was then performed in antibody buffer at room temperature (1 h). After two washes in DPBS, incubation with secondary antibodies proceeded for 1 h. The secondary antibodies used were Alexa Fluor-conjugated goat anti-rabbit IgG or anti-mouse IgG. The coverslips were finally mounted in Fluoromount-G solution (CliniSciences) for immunofluorescence visualization using confocal microscopy.
Internalization experiments and immunocytofluorescent labeling of internalized receptors. For all experiments, cells were washed once with serum-free medium and incubations with pharmacological compounds were performed in serum-free medium. For fluorescence experiments with cell lines, LLC-PK1 cells were incubated with BTX-AF488 (1:1000) for 30 min at 4°C, washed with DMEM and incubated at 37°C for 30 min, or incubated with BTX-AF488 (1:1000) plus drugs, or none, directly at 37°C for 15, 30, or 60 min. Transferrin Alexa Fluor 546 conjugate or LysoTracker Red DND-99 was added to the medium with BTX conjugate during the whole internalization experiment or the last 30 min of incubation, respectively. Membrane-bound BTX conjugate was removed with a 15 min acid wash and cells were fixed with PFA/sucrose. For experiments with infected neurons, primary mouse anti-Flag antibody (1: 2000) was complexed with secondary anti-mouse chicken Alexa Fluor 594 antibody (1:800; fluorescent antibody complex) in Neurobasal medium/HEPES 20 mM during 45 min at room temperature before incubation with neurons. Acute treatment consisted of exposing neurons (12-14 DIV) to ligands (10 M) for 1 h at 37°C, whereas a pretreatment with ligands (10 M) for 24 h before the 1 h exposure to the antibody complex was performed for sustained treatment. Cells were fixed and incubated with anti-chicken goat Alexa Fluor 488 antibody (1:500) without permeabilization to label receptors that were still present on plasma membranes. For neurons from raphe cultures, cells were then permeabilized to detect 5-HT with anti-5-HT antibodies.
Microscopy. Immunofluorescence images were generated using a Leica TCS SP2 AOBS laser scanning confocal microscope (63ϫ oil-immersion lens). Contrast and brightness were chosen to ensure that all pixels were within the linear range. Images were the product of threefold line averages. In all cases, emission and excitation filters proper to each fluorophore were used sequentially and the absence of cross talk between different channels was checked with selectively labeled preparations. Leica pictures (.lei) were saved as TIFF images and plates were assembled using Adobe Photoshop CS2 (Adobe Systems). Background was lowered using Gaussian blur (radius 1 pixel) and contrast and brightness of images displayed in figures were modified using Adobe Photoshop CS2 only for illustrations.
Image analysis. For receptor distribution assays in LLC-PK1 cells, quantification of the internalized receptors was done on cells that had been exposed to a 15 min acid wash to remove cell membrane receptor's labeling. Fluorescence was measured using ImageJ on 30 cells per condition. For analysis of colocalization of BTX with rab4-GFP and rab5-GFP, images were median filtered (1 pixel), threshold was adjusted, and colocalization was quantified by colocalization threshold. For receptor distribution assay in neurons, images of individual cells were obtained with a 2.2ϫ zoom. Total and intracellular fluorescence were quantified on a region of interest (ROI) for 19 -84 neurons per condition. Cells were randomly chosen with phenotypic consideration to avoid dead, dividing, or receptor overexpressing cells. Total levels of receptor expression were quantified as fluorescence obtained for each cell with the secondary antimouse chicken Alexa Fluor 594 antibody labeling. Intracellular labeling was quantified as the Alexa Fluor 594 antibody labeling inside an ROI delimited into the neuron just inside the cell membrane. Internalized receptors were quantified as the ratio of intracellular labeling to total labeling.
Live cell imaging. Experiments were performed on stably transfected LLC-PK1 cells or transduced raphe neurons grown on 35 mm glass base dishes (IWAKI) with culture medium supplemented with 20 mM HEPES. Time-lapse imaging was performed at 37°C using a spinning-disk microscope mounted on an inverted motorized confocal microscope (Leica TCS SP2) through a 100ϫ1.4 NA PL-APO objective lens. The apparatus is composed of a Yokogawa CSU-22 spinning disk head, a Roper Scientific laser lounge, a Photometrics Coolsnap HQ2 CCD camera for image acquisition, and MetaMorph software (MDS) to control the setup. Acquisition parameters were 100 -300 ms exposure for the GFP channel. Laser was set to 30% in each case. Movies shown in figures correspond to stacks resulting from a maximal intensity projection through the z-axis performed with the MetaMorph software (National Institutes of Health Image). Trajectories of moving vesicles were tracked with the MTrackJ Plugin of ImageJ software developed by Erik Meijering (Biomedical Imaging Group Rotterdam of the Erasmus MC-University Medical Center Rotterdam, The Netherlands).
Statistical analyses. Data are presented as means Ϯ SEM. Statistical significance was assessed using one-way or two-way ANOVA followed by Dunnett's or Bonferroni's test. Critical level of significance was set at p Յ 0.05.
Results

BBS and Flag tagged 5-HT 1A receptors are properly targeted and functional
We developed two constructs of the 5-HT 1A R, one tagged with a sequence coding for BBS for cell line transfection (BBS-5-HT 1A ; Fig. 1A1 ), and the other tagged with BBS and a Flag sequence for primary cultured rat E14 raphe and E18 hippocampal neuron lentiviral vector transduction (BBS-Flag-5-HT 1A , Fig. 1A2 ). These tags were added at the N-terminal tail of the receptor to allow visualization of 5-HT 1A R that was trafficking from its functional localization, the plasma membrane, using fluorophore-conjugated BTX or anti-Flag antibodies (Fig. 1B) . BBS fusion proteins were previously shown to be appropriate to follow AMPA receptor trafficking (Sekine-Aizawa and Huganir, 2004) , GABA B receptor (Hannan et al., 2011) , and 5-HT 3 receptor internalization (Morton et al., 2011) . In permeabilized cells expressing tagged-5-HT 1A R, a strong perinuclear BTX labeling was observed, presumably corresponding to BBS-5-HT 1A R newly synthetized and still localized in endoplasmic reticulum or Golgi apparatus in both transfected LLC-PK1 cells (Fig. 1B1, arrowhead) and transduced hippocampal neurons (Fig. 1B3, arrowhead) . Surface labeling with fluorescent BTX or Flag immunofluorescent staining performed on fixed cells without permeabiliza-tion demonstrated a strong basolateral plasma membrane localization of the BBS-5-HT 1A R in LLC-PK1 cells (Fig. 1B2,  arrow) and of BBS-Flag-5-HT 1A R in the soma and dendrites of hippocampal neurons (Fig. 1B4, arrow) . In these two models, targeting of BBS-5-HT 1A R and BBS-Flag-5-HT 1A R was similar to that of tagged 5-HT 1A R used in previous studies (Langlois et al., 1996; Jolimay et al., 2000) .
To verify the specificity of BTX binding onto BBS- (Darmon et al., 1998) , we also observed that BTX (100 nM) did not interfere with its specific binding to BBS-5-HT 1A R (Fig. 1D) . Determination of the affinity constant of (Fig. 1E) . These results indicated that BBS incorporation into the N terminus of the 5-HT 1A R did not alter its pharmacological profile and functional responses to ligands (Langlois et al., 1996; Darmon et al., 1998) . Overall, the inserted BBS had the capacity to operate as a functionally silent reporter of 5-HT 1A R trafficking. 
Tagged-5-HT 1A receptors are constitutively internalized in transfected LLC-PK1 cells and in transduced neurons
Extracellular BBS and Flag tag allow overcoming limitations observed with GFP fusion proteins to study receptor endocytosis. Indeed, such GFP fusion proteins can perturb localization and signaling of the tagged receptor and its interactions with partner proteins, mainly because of steric constraints due to the relatively large size of GFP (238 amino acids). Furthermore, with such fusion proteins, it is impossible to distinguish internalized receptors from receptors on the way to the plasma membrane. Usually, cycloheximide is used to limit de novo receptor synthesis, but this drug inhibits all protein synthesis, which could alter trafficking mechanisms that need biosynthesis of regulatory proteins. In contrast, BBS tag allowed the labeling of the receptor at the plasma membrane and its follow up during its intracellular traffic.
In LLC-PK1 cells stably expressing BBS-5-HT 1A R, fluorescent BTX bound onto BBS-5-HT 1A R at 4°C was localized exclusively at the plasma membrane (Fig. 2A1 ). When cells were placed at 37°C for 30 min in serum-free medium, the BBS-5-HT 1A R labeled by fluorescent BTX was observed within intracellular structures with vesicular appearance (Fig. 2A2 ). To clearly identify intracellular BBS-5-HT 1A R from BBS-5-HT 1A R that was still localized at the plasma membrane, we performed a labeling protocol with an acid wash. In a first step, BBS-5-HT 1A R-expressing cells were exposed to fluorescent BTX-AF488 (green) in serumfree medium at 37°C for 1 h (Fig. 2B1) . Then, half of living LLC-PK1 cells expressing BBS-5-HT 1A R were acid washed (Fig. 2B2 ) to unlabel the plasma membrane while the other half was maintained under control conditions (Fig. 2B1) . After fixation, BBS-5-HT 1A R still bound to the plasma membrane could be labeled using BTX-AF555 (red). This strategy allowed labeling of internalized receptor (green) or plasma membrane-bound receptor (Fig. 2B1, yellow or B2, red) . In complementary experiments, we used the same acid wash strategy after labeling BBS-5-HT 1A R with [
125 I]BTX. We determined that after 20 min at 20°C, BBS-5-HT 1A R internalization followed by intracellular [
125 I]BTX accumulation reached 11.42 Ϯ 0.84% of total [
125 I]BTX binding in control conditions and neither 5-HT (10 M), the 5-HT 1A R partial agonist 8-OH-DPAT (10 M), alone or in combination with the antagonist WAY100635 (10 M), nor 5-HT 1A R inverse agonists (methiothepin and spiperone, 10 M), added during incubation with [
125 I]BTX significantly affected BBS-5-HT 1A R internalization (Fig. 2C) .
We then investigated the intracellular pathway followed by constitutively internalized BBS-5-HT 1A R. In LLC-PK1-transfected cells, constitutive BBS-5-HT 1A R endocytosis was found to follow the same pathway as transferrin (TRF) endocytosis (Fig. 3A1) . In particular, both BBS-5-HT 1A R and TRF internalizations were blocked by high sucrose (0.35 M), an inhibitor of clathrin-coated pits-mediated endocytosis (Fig. 3A2,B) . In addition, monensin, a cation ionophore that blocks recycling (Stein et al., 1984) , produced a significant increase in intracellular BBS-5-HT 1A R, indicating that BBS-5-HT 1A R normally underwent recycling to the plasma membrane (Fig. 3A3,B) . Further experiments were performed using cells transfected with rab5-GFP or rab4-GFP, markers of early endosomes and fast recycling vesicles (Rosenfeld et al., 2002; Seachrist and Ferguson, 2003) . After 15 min of internalization, 67% of vesicles labeled with BBS-5-HT 1A R were expressing rab5-GFP (Fig.  3C1) and 72% of vesicles labeled with BBS-5-HT 1A R were expressing rab4-GFP when internalization was pursued to 30 min (Fig. 3C2) . Live confocal imaging on LLC-PK1 BBS-5-HT 1A R-expressing cells clearly identified BBS-5-HT 1A R endocytosis and recycling events (Fig. 3D, arrow) . The weak colabeling of internalized BBS-5-HT 1A R with LysoTracker Red-DND99, a marker of late endosomes, showed that BBS-5-HT 1A R was scarcely degraded 1 h after internalization (Fig.  3E) . Altogether, these results suggested that the constitutively internalized BBS-5-HT 1A R in LLC-PK1 cells followed a clathrin-coated pitted endocytic pathway, and were mainly sorted to a fast recycling pathway with low degradation.
For experiments on neurons, acid wash strategy could not be used to determine whether constitutive internalization occurred as in LLC-PK1 cells because it was too damaging for cells. After incubation, in a serum-free medium, at 37°C for 60 min with a fluorescent antibody complex, vesicular structures endowed with BBS-Flag-5-HT 1A R (Fig. 4A, arrows) could be detected in the soma of hippocampal (Fig. 4A3 ) and serotonergic raphe ( Fig.  4B3 ; identified by 5-HT immunostaining) neurons. Internalized BBS-Flag-5-HT 1A R (Fig. 4A2,B2 , red) could be clearly differentiated from BBS-Flag-5-HT 1A R still localized at the cell membrane (Fig. 4A1,B1 , green; A3,B3, yellow). Quantification showed that 9% of BBS-Flag-5-HT 1A R were internalized in soma and proximal dendrites of serotonergic raphe neurons, under basal conditions, in the absence of receptor ligands (Fig. 4C) . A pretreatment (24 h) with WAY-100635 (10 M) or spiperone (10 M) had no effect on BBS-Flag-5-HT 1A R endocytosis in serotonergic raphe neurons, suggesting that BBS-Flag-5-HT 1A R internalization was not induced by endogenous 5-HT released in raphe culture and was independent of any constitutive activity of the receptor. In living neurons also, we showed that the tagged-5-HT 1A R underwent internalization followed by a rapid recycling that could be visualized on the time lapse of live confocal imaging showing single events of internalization and recycling (Fig. 4D, arrows) . Internalized tagged-5-HT 1A R were trafficking inside the soma or anterogradely between the soma and proximal dendrites (Fig. 4E,  arrows) .
Agonist-dependent endocytosis of BBS-Flag-5-HT 1A R depends on the neuronal phenotype, agonist strength, and duration of stimulation Under our primary culture conditions, raphe cultures at 14 DIV contained equal amounts of glial cells and neurons, and among them, ϳ10% were serotonergic. Among the latter neurons, the proportion of those expressing BBS-Flag-5-HT 1A R ranged between 45 and 75% from one experiment to another. In all cases, analyses were performed on neurons with comparable levels of BBS-Flag-5-HT 1A R expression. Interestingly, levels of BBS-Flag-5-HT 1A R were not modified by sustained agonist treatments (Table 1), indicating that quantification of BBS-Flag-5-HT 1A R internalization quantification could not be biased by changes in expression receptor levels, thereby discarding the possible occurrence of nonspecific activation of the promotor controlling receptor expression, as can be observed in transfected cell lines (Cowen et al., 1997) .
No change in BBS-Flag-5-HT 1A R endocytosis was observed in serotonergic raphe neurons after cell incubation for 1 h with the partial 5-HT 1A R agonist, 8-OH-DPAT (10 M; Assié et al., 1999; Fig. 5 A, B) . However, a marked increase of internalized BBSFlag-5-HT 1A R fraction, up to 260% of control, was observed in serotonergic raphe neurons after an incubation with 8-OH-DPAT for 24 h (Fig. 5 A, B) . This effect was specific of the serotonergic neuron phenotype because no internalization was detected in nonserotonergic neurons either after acute or sustained treatment with 8-OH-DPAT (Fig. 5B, right graph) . On the 
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other hand, the two full 5-HT 1A R agonists, 5-CT and 5-HT (Assié et al., 1999) , induced BBS-Flag-5-HT 1A R endocytosis after 1 h treatment only, up to the same level as that noted after a 24 h treatment with 8-OH-DPAT. As shown in Figure 5 ,A and B, in all cases, agonist-induced BBS-Flag-5-HT 1A R internalization in serotonergic raphe neurons was prevented when WAY-100635 (10 M) was added with the agonist. Increases in total receptor endocytosis after 24 h treatment (Fig. 5B) were the consequence of a shift of the maximum frequency of neurons displaying higher internalization levels with agonists (14% for 8-OH-DPAT, 16% for 5-HT, and 22% for 5-CT) compared with control (4%; Fig. 5C ). Altogether, these data showed that 5-CT was the more potent agonist to induce receptor internalization.
In contrast, whether treatment with 8-OH-DPAT was acute or sustained, this partial 5-HT 1A R agonist did not induce BBS-Flag-5-HT 1A R internalization in hippocampal neurons (Fig. 6A-C) . Similarly, 1 h treatment with the two full agonists, 5-CT and 5-HT, had no effect on receptor endocytosis (Fig. 6A,B, left graph) . However, when hippocampal neurons were exposed for 24 h to either of the latter two agonists, they exhibited a heterogeneous response, with no internalization in some (LOW) neurons but a high level of internalization (HIGH) in others. Quantitative analyses showed that LOW neurons, with an internalization rate (0 -10%) at the same low level as under basal (without drug) conditions, represented 59.6 and 65.1% of all hippocampal neurons exposed to 5-CT and 5-HT, respectively (Fig. 6C, LOW) . The other 40.4 and 34.9% of neurons, respectively, corresponded to those that presented a clear-cut full agonist-induced BBS-Flag-5-HT 1A R internalization, with an internalization rate up to 30% (Fig. 6C, HIGH) .
Therefore, BBS-Flag-5-HT 1A R was faintly but constitutively internalized in both raphe and hippocampal neurons. However, agonistinduced BBS-Flag-5-HT 1A R internalization depended on neuronal population, efficacy of (partial or full) agonists, and duration of treatment with these ligands.
Discussion
We investigated the trafficking properties of the 5-HT 1A R expressed in the LLC-PK1 cell line and raphe versus hippocampal neurons in primary culture. For this purpose, we developed a new functional construct, BBS-tagged-5-HT 1A R, which allowed visualization of 5-HT 1A R endocytosis and recycling. Our data showed that the receptor underwent a constitutive, agonist-independent internalization in both LLC-PK1 cells and rat brain neurons. The internalized receptor followed the clathrin-dependent pathway and was predominantly recycled back to the plasma membrane, with very little degradation. In addition, agonist-dependent 5-HT 1A R internalization was demonstrated in neurons, with striking differences between serotonergic raphe neurons and nonserotonergic neurons in raphe and hippocampus. tion) occurred in hippocampus after acute or chronic stimulation, either by exogenous 5-HT 1A R agonist or by 5-HT under SSRI treatment (Lanfumey and Hamon, 2000; Le Poul et al., 2000; Hensler, 2003) . 5-HT 1A R are G i/o -coupled receptors but the type of inhibitory ␣-subunit differs in raphe (preferentially G␣i3) and in brain areas receiving serotonergic projections such as the hippocampus (preferentially G␣o) (Mannoury La Cour et al., 2006) . These differences could contribute to differences in signaling pathways, and possibly in traffic regulation after receptor stimulation. In particular, 5-HT 1A R stimulation was found to decrease ERK phosphorylation in the hippocampus (Chen et al., 2002) but to rapidly increase this process in the raphe (Sullivan et al., 2005) . As MAPK pathways regulate gene expression and physiological response, such differential changes could account for long-term neuronal adaptations after chronic SSRI treatment in the raphe but not in the hippocampus. Antidepressant efficacy of SSRI requires 3-4 weeks of treatment with these drugs, a delay which corresponds to the time necessary for 5-HT 1A autoreceptor desensitization (Artigas et al., 1994; Lanfumey and Hamon, 2000; Blier and Ward, 2003) . Clinical trials explored the possibility to decrease SSRI delay of action by blocking 5-HT 1A receptors (Artigas et al., 1994; Geretsegger et al., 2008) . However, whereas blocking 5-HT 1A autoreceptor activation could have a beneficial effect by inhibiting 5-HT 1A autoreceptor-mediated feedback on serotonin release, adverse effects could occur on the therapeutic action of antidepressant drugs due to the beneficial effect of stimulating postsynaptic 5-HT 1A R in corticolimbic areas (Celada et al., 2013) . Combining 5-HT 1A R partial agonism with SERT inhibition by administering SSRI and pindolol (acting as a partial 5-HT 1A R agonist) or new antidepressant drugs such as vilazodone and vortioxetine (with pharmacological profiles that combine SSRI and partial 5-HT 1A R agonist properties) appeared to be more efficient (Hamon and Blier, 2013) . These pharmacological strategies presumably achieve beneficial effects on depression treatment by increasing extracellular 5-HT and promoting 5-HT 1A autoreceptor internalization to limit the inhibitory feedback loop on 5-HT release (Stahl et al., 2013) .
